Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 164

Similar articles for PubMed (Select 22163120)

1.

CD34-positive stem cells: in the treatment of heart and vascular disease in human beings.

Mackie AR, Losordo DW.

Tex Heart Inst J. 2011;38(5):474-85. Review.

2.

CD34 hybrid cells promote endothelial colony-forming cell bioactivity and therapeutic potential for ischemic diseases.

Lee JH, Lee SH, Yoo SY, Asahara T, Kwon SM.

Arterioscler Thromb Vasc Biol. 2013 Jul;33(7):1622-34. doi: 10.1161/ATVBAHA.112.301052. Epub 2013 May 2.

3.

Exosomes from human CD34(+) stem cells mediate their proangiogenic paracrine activity.

Sahoo S, Klychko E, Thorne T, Misener S, Schultz KM, Millay M, Ito A, Liu T, Kamide C, Agrawal H, Perlman H, Qin G, Kishore R, Losordo DW.

Circ Res. 2011 Sep 16;109(7):724-8. doi: 10.1161/CIRCRESAHA.111.253286. Epub 2011 Aug 11.

4.

Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies.

Kawamoto A, Asahara T.

Catheter Cardiovasc Interv. 2007 Oct 1;70(4):477-84. Review.

PMID:
17894361
5.

Clinical potential of adult vascular progenitor cells.

Kumar AH, Caplice NM.

Arterioscler Thromb Vasc Biol. 2010 Jun;30(6):1080-7. doi: 10.1161/ATVBAHA.109.198895. Epub 2010 May 7. Review.

6.

Umbilical cord blood stem cells for myocardial repair and regeneration.

Greco N, Laughlin MJ.

Methods Mol Biol. 2010;660:29-52. doi: 10.1007/978-1-60761-705-1_3.

PMID:
20680811
7.

Bone marrow-derived mononuclear cell therapy induces distal angiogenesis after local injection in critical leg ischemia.

Duong Van Huyen JP, Smadja DM, Bruneval P, Gaussem P, Dal-Cortivo L, Julia P, Fiessinger JN, Cavazzana-Calvo M, Aiach M, Emmerich J.

Mod Pathol. 2008 Jul;21(7):837-46. doi: 10.1038/modpathol.2008.48. Epub 2008 May 16.

8.

Pivotal role of lnk adaptor protein in endothelial progenitor cell biology for vascular regeneration.

Kwon SM, Suzuki T, Kawamoto A, Ii M, Eguchi M, Akimaru H, Wada M, Matsumoto T, Masuda H, Nakagawa Y, Nishimura H, Kawai K, Takaki S, Asahara T.

Circ Res. 2009 Apr 24;104(8):969-77. doi: 10.1161/CIRCRESAHA.108.192856. Epub 2009 Mar 26.

9.

Novel cell-free strategy for therapeutic angiogenesis: in vitro generated conditioned medium can replace progenitor cell transplantation.

Di Santo S, Yang Z, Wyler von Ballmoos M, Voelzmann J, Diehm N, Baumgartner I, Kalka C.

PLoS One. 2009 May 21;4(5):e5643. doi: 10.1371/journal.pone.0005643.

10.

Long-term benefit of intracardiac delivery of autologous granulocyte-colony-stimulating factor-mobilized blood CD34+ cells containing cardiac progenitors on regional heart structure and function after myocardial infarct.

Pasquet S, Sovalat H, Hénon P, Bischoff N, Arkam Y, Ojeda-Uribe M, Bouar Rl, Rimelen V, Brink I, Dallemand R, Monassier JP.

Cytotherapy. 2009;11(8):1002-15. doi: 10.3109/14653240903164963.

PMID:
19929464
12.

Stem cells and cardiovascular disease.

Abbott JD, Giordano FJ.

J Nucl Cardiol. 2003 Jul-Aug;10(4):403-12. Review.

PMID:
12900745
13.

The relative potency and safety of endothelial progenitor cells and unselected mononuclear cells for recovery from myocardial infarction and ischemia.

Sekiguchi H, Ii M, Losordo DW.

J Cell Physiol. 2009 May;219(2):235-42. doi: 10.1002/jcp.21672. Review.

PMID:
19115244
14.
15.

Transplantation of low dose CD34+KDR+ cells promotes vascular and muscular regeneration in ischemic limbs.

Madeddu P, Emanueli C, Pelosi E, Salis MB, Cerio AM, Bonanno G, Patti M, Stassi G, Condorelli G, Peschle C.

FASEB J. 2004 Nov;18(14):1737-9. Epub 2004 Sep 2.

16.

Regeneration of the vascular compartment.

Becher MU, Nickenig G, Werner N.

Herz. 2010 Aug;35(5):342-51. doi: 10.1007/s00059-010-3360-0. Review.

PMID:
20842474
17.

Intramyocardial, autologous CD34+ cell therapy for refractory angina.

Losordo DW, Henry TD, Davidson C, Sup Lee J, Costa MA, Bass T, Mendelsohn F, Fortuin FD, Pepine CJ, Traverse JH, Amrani D, Ewenstein BM, Riedel N, Story K, Barker K, Povsic TJ, Harrington RA, Schatz RA; ACT34-CMI Investigators.

Circ Res. 2011 Aug 5;109(4):428-36. doi: 10.1161/CIRCRESAHA.111.245993. Epub 2011 Jul 7.

18.

Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial.

Kawamoto A, Katayama M, Handa N, Kinoshita M, Takano H, Horii M, Sadamoto K, Yokoyama A, Yamanaka T, Onodera R, Kuroda A, Baba R, Kaneko Y, Tsukie T, Kurimoto Y, Okada Y, Kihara Y, Morioka S, Fukushima M, Asahara T.

Stem Cells. 2009 Nov;27(11):2857-64. doi: 10.1002/stem.207.

19.

Human adult vena saphena contains perivascular progenitor cells endowed with clonogenic and proangiogenic potential.

Campagnolo P, Cesselli D, Al Haj Zen A, Beltrami AP, Kränkel N, Katare R, Angelini G, Emanueli C, Madeddu P.

Circulation. 2010 Apr 20;121(15):1735-45. doi: 10.1161/CIRCULATIONAHA.109.899252. Epub 2010 Apr 5.

20.

Bone marrow-derived endothelial progenitor cells: isolation and characterization for myocardial repair.

Ii M.

Methods Mol Biol. 2010;660:9-27. doi: 10.1007/978-1-60761-705-1_2.

PMID:
20680810
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk